Apoptosis, necroptosis and autophagy in colorectal cancer: Associations with tumor aggressiveness and p53 status.
Apoptosis
/ physiology
Autophagy
/ physiology
Colorectal Neoplasms
/ genetics
ErbB Receptors
/ genetics
Female
Humans
Lymphatic Metastasis
/ genetics
Male
Middle Aged
Necroptosis
/ physiology
Neoplasm Invasiveness
/ genetics
Prognosis
Proto-Oncogene Proteins p21(ras)
/ genetics
Tumor Suppressor Protein p53
/ genetics
Cleaved caspase-3
Colorectal cancer
Microtubule-associated protein-1 light chain-3
Pathological aggressiveness
Phosphorylated-mixed-lineage kinase domain-like protein
p53
Journal
Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
18
01
2019
revised:
05
04
2019
accepted:
26
04
2019
pubmed:
18
5
2019
medline:
15
1
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Cleaved caspase-3 (CC3), phosphorylated-mixed-lineage kinase domain-like protein (p-MLKL), and microtubule-associated protein-1 light chain-3B (LC3B) have pivotal functions in apoptosis, necroptosis, and autophagy, respectively. In vitro studies have shown that interaction of these proteins are complex and their roles in cancer can be influenced by many factors. However, these findings are not adequately assessed in human tissues. Here, we determined CC3, p-MLKL, and LC3B expression in colorectal cancers (CRCs), and assessed their associations with clinicopathological parameters, and with KRAS and p53 status. We immunohistochemically assessed 113 CRC specimens for levels of CC3, p-MLKL, LC3B, and p53. KRAS gene status was analyzed using the Scorpion- amplification refractory mutation system. High levels of CC3 (CC3 To the best of our knowledge, this is the first study to examine the combination of CC3/LC3B and p-MLKL expression in clinical CRC samples and to correlate these expression data with clinicopathological parameters and EGFR and p53 status. Our results suggest that necroptosis is a rare process in CRC, apoptosis and autophagy are upregulated in aggressive CRCs, and p53 mutation may lead to the upregulation of autophagy.
Identifiants
pubmed: 31097354
pii: S0344-0338(19)30115-3
doi: 10.1016/j.prp.2019.04.017
pii:
doi:
Substances chimiques
KRAS protein, human
0
Tumor Suppressor Protein p53
0
EGFR protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
152425Informations de copyright
Copyright © 2019 Elsevier GmbH. All rights reserved.